Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9M47
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,599
Award facts
- Contract value 100% obligated
- $40,598.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,598.92 to AmerisourceBergen Drug Corp for Cosentyx Unoready 300 mg pen 2ml, with an ultimate completion date of December 9, 2025. This is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. The contract represents a delivery order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cosentyx (secukinumab) is a biologic medication used to treat autoimmune and inflammatory conditions, reflecting the vendor's established role in supplying specialty pharmaceuticals to support military healthcare programs. This award demonstrates AmerisourceBergen's continued participation in DLA's pharmaceutical supply chain operations and its capability to fulfill federal medical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26F9M47?
SPE2DR26F9M47 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F9M47 worth?
The government has obligated $40,599 on SPE2DR26F9M47.
Is contract SPE2DR26F9M47 an order under another contract?
Yes. SPE2DR26F9M47 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9M47 competed?
The extent of competition for SPE2DR26F9M47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award